CIK 0001676725 · Large accelerated filer
IDEAYA Biosciences, Inc.
Sign in to watch- Ticker
- IDYA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474268251
- Phone
- 650-443-6209
- Business address
- 5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $985,397
- in 1 filing, $985K under 10b5-1 plans
Net −$985,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-09 | Dillon Michael P. SVP, Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −5,000 | 57,500 | ||
| 2021-02-09 | Lackner Mark SVP, Head of Biology | Option exercise | +1,104 | $6.98 | $8K | 1,104 |
| 2021-02-09 | Lackner Mark SVP, Head of Biology | Sale | −1,104 | $21.05 | $23K | 0 |
| 2021-02-09 | Lackner Mark SVP, Head of Biology | Option exercise · Stock Option (right to buy) | −1,104 | 33,610 | ||
| 2021-02-08 | Lackner Mark SVP, Head of Biology | Option exercise | +300 | $6.98 | $2K | 300 |
| 2021-02-08 | Lackner Mark SVP, Head of Biology | Sale | −100 | $21.02 | $2K | 200 |
| 2021-02-08 | Lackner Mark SVP, Head of Biology | Sale | −200 | $21.00 | $4K | 0 |
| 2021-02-08 | Lackner Mark SVP, Head of Biology | Option exercise · Stock Option (right to buy) | −300 | 34,714 | ||
| 2021-02-02 | BVF PARTNERS L P/IL See Explanation of Responses | Sale | −25,234 | $18.00 | $454K | 1,642,186 |
| 2021-02-02 | BVF PARTNERS L P/IL See Explanation of Responses | Sale | −16,850 | $18.00 | $303K | 1,188,131 |
| 2021-02-02 | BVF PARTNERS L P/IL See Explanation of Responses | Sale | −4,325 | $18.00 | $78K | 233,150 |
| 2021-01-26 | Lackner Mark SVP, Head of Biology | Option exercise | +377 | $4.62 | $2K | 1,378 |
| 2021-01-26 | Lackner Mark SVP, Head of Biology | Option exercise | +1,123 | $6.98 | $8K | 2,501 |
| 2021-01-26 | Lackner Mark SVP, Head of Biology | Sale | −1,701 | $18.30 | $31K | 800 |
| 2021-01-26 | Lackner Mark SVP, Head of Biology | Sale | −800 | $18.79 | $15K | 0 |
| 2021-01-26 | Lackner Mark SVP, Head of Biology | Option exercise · Stock Option (right to buy) | −377 | 61,760 | ||
| 2021-01-26 | Lackner Mark SVP, Head of Biology | Option exercise · Stock Option (right to buy) | −1,123 | 35,014 | ||
| 2020-12-22 | Hata Yujiro S President and CEO | Option exercise | +8,000 | $4.31 | $34K | 666,286 |
| 2020-12-22 | Hata Yujiro S President and CEO | Option exercise · Stock Option (right to buy) | −8,000 | 486,055 | ||
| 2020-12-18 | Dillon Michael P. SVP, Chief Scientific Officer | Option exercise | +7,750 | $4.31 | $33K | 98,789 |
Page 13 of 19 · 370 trades